针对老大脑的神经可塑性:通过认知策略恢复突触
Spandana Rajendra Kopalli1, Mayur B Kale2, Akanksha Yadav2
1Department of Bioscience and Biotechnology, Sejong University, Gwangjin-Gu, Seoul, 05006, Republic of Korea.
Biogerontology
|February 25, 2026
概括
神经可塑性,大脑的大脑.
科学领域:
- 神经科学是一个神经科学.
- 衰老研究研究 衰老研究
- 认知科学 认知科学
背景情况:
- 认知衰老的特点是记忆力,处理速度和执行功能的下降.
- 这些下降与神经可塑性降低有关,包括突触可塑性和神经发生.
- 氧化应激和神经炎症等因素加快了与年龄相关的认知恶化.
研究的目的:
- 审查神经可塑性在认知衰老中的作用.
- 讨论促进神经可塑性促进认知健康的干预措施.
- 突出个性化干预的挑战和未来方向.
主要方法:
- 关于衰老中的神经可塑性机制的文献综述.
- 对影响神经可塑性的因素的分析.
- 检查当前和潜在的干预措施.
主要成果:
- 突触可塑性支持学习,但人类的成年神经发生是有限的.
- 功能重组有助于认知功能,尽管与年龄相关的变化.
- 像认知训练和运动这样的干预措施是有前途的,但需要个性化.
结论:
- 个性化策略对于增强老化大脑的神经可塑性至关重要.
- 未来的研究应该专注于调节特定的神经可塑性过程.
- 有针对性的干预措施可能会延迟或逆转与年龄相关的认知衰退.
相关概念视频
Neuroplasticity
2.1K
Neuroplasticity reflects the brain's remarkable capacity to adapt and evolve, responding dynamically to learning, experiences, or injury by reorganizing its neural circuitry. This reorganization involves creating new neural connections and refining old ones through a series of biological processes that contribute to the brain's lifelong development and adaptability.
2.1K
Cognitive Development During Adulthood
988
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
988
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
735
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
735
Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Long-term Potentiation
3.7K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...
Hebbian LTP
LTP can occur when...
3.7K
Long-term Potentiation
59.0K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
59.0K


